Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCD CURE: Nexplanon in Women With Sickle Cell Disease
NCT05730205Phase 4Active, not recruiting
- Sponsor
- University of Pennsylvania
- Start
- Aug 2023
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of etonogestrel in sickle cell disease (SCD), sponsored by University of Pennsylvania. Started Aug 2023; status: active, not recruiting.
02
Drugs
etonogestrel
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT05730205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05730205.